When You Postpone the Differential Between Alopecia Areata and AGA, the Whole Treatment Plan Falls Out of Sync — How to Read the Autoimmune Attack on Hair Follicles Versus Dihydrotestosterone Sensitivity, and Where Stem Cell Conditioned Media Fits, Organized by Dr. Moriwaki2026.07.22

Among the patients who come to our consultation room with concerns about hair thinning, quite a few arrive with the conclusion already fixed in their mind: “I think this is AGA, so I would like stem cell conditioned media treatment.” Yet when we actually examine the scalp, we sometimes find sharply demarcated bald patches or abnormal hair root morphology — and what looked like AGA turns out to be alopecia areata. Even when the surface phenomenon is the same “my hair looks thinner,” if you do not first settle the alopecia areata vs AGA differential, the pathologies you are targeting are completely different, and the entire treatment design falls out of sync. In this column, Dr. Shin Moriwaki, the supervising physician of AVAN TOKYO Ginza, organizes the fundamental differences between alopecia areata — driven by autoimmunity attacking hair follicles — and AGA — driven by androgen sensitivity that miniaturizes follicles — how to distinguish them clinically, and where stem cell conditioned media fits as an option.

Key Points of This Article

・Alopecia areata and AGA are entirely different diseases, and if you advance treatment without first sorting out the alopecia areata vs AGA differential, the very interpretation of “is it working?” collapses.

・Alopecia areata is an inflammatory disease in which CD8-positive T lymphocytes attack the hair bulb; AGA is essentially the miniaturization of hair follicles driven by dihydrotestosterone.

・Sharply demarcated bald patches, rapid progression, nail pitting, and the presence of exclamation-mark hairs are key clues that raise suspicion of alopecia areata.

・Stem cell conditioned media is positioned as an adjunctive therapy that reshapes the follicular microenvironment; using it alone in highly active alopecia areata is not recommended.

・The honest sequence — “first, dermatologic evaluation for autoimmunity” → “then, differential from AGA” → “then, add regenerative medicine when appropriate” — is what keeps patients from taking the long way around.

Alopecia Areata vs AGA Differential — It All Starts from Recognizing They Are Different Diseases

AGA: Follicular Miniaturization Driven by Dihydrotestosterone

The core pathology of AGA (androgenetic alopecia) is the conversion of testosterone into dihydrotestosterone (DHT) by 5-alpha reductase, and the binding of DHT to susceptible follicles in the frontal and vertex regions. DHT signaling shortens the anagen phase of the hair cycle, raises the proportion of telogen hairs, and progressively miniaturizes the follicles themselves. Clinically, it is characterized by diffuse thinning with blurred borders, variability in hair caliber within a single follicular unit (thick and thin hairs coexisting), and a slow progression measured in years.

Alopecia Areata: T-Lymphocyte Attack on the Hair Bulb

Alopecia areata, by contrast, is an autoimmune inflammatory alopecia. The hair bulb, which should normally be protected by “immune privilege,” becomes a target of CD8-positive T lymphocytes upon some trigger, and anagen hairs shed abruptly. Its hallmarks include sharply bordered patches from the size of a coin to a palm, rapid progression completed within days to weeks, exclamation-mark hairs at the edge of a patch (hairs tapering toward the root like an “!”), and nail pitting. Severity is graded through subtypes such as patchy, multi-focal, totalis, universalis, and ophiasis.

The “Not AGA” Signs We Look for in the Consultation Room

Sharpness of the Border and Ease of Hair Pull

AGA presents with blurred borders, whereas alopecia areata shows sharply demarcated patches. If a pull test (a clinical maneuver in which we lightly tug and count how many hairs come out) is significantly positive at the edge of a patch, we regard the disease as being in an active phase.

Exclamation-Mark Hairs, Broken Hairs, and Black Dots

On dermoscopy (trichoscopy), a bald patch may reveal exclamation-mark hairs tapering toward the root, broken hairs snapped mid-shaft, and black dots retained within the follicle — findings that are not seen in AGA. They reflect transient follicular destruction driven by autoimmunity.

Nail Pitting and Associated Systemic Signs

In alopecia areata, nail pitting coexists in a certain proportion of cases. Associations with atopic dermatitis, thyroid autoimmunity (such as Hashimoto’s disease), and vitiligo are well known, and the presence of such comorbidities strengthens the case for an autoimmune background.

Where Stem Cell Conditioned Media Fits — AGA Is the Main Battlefield, Alopecia Areata Is Adjunctive

Stem cell conditioned media is a collective term for the secretome contained in the culture supernatant of mesenchymal stem cells — a wide range of growth factors (VEGF, IGF-1, HGF, KGF, and others), cytokines, and extracellular vesicles such as exosomes. It is positioned as an adjunctive therapy that works on the environment surrounding hair follicle stem cells and dermal papilla cells, aiming to “rehabilitate the follicular microenvironment” through supporting the anagen phase, improving perifollicular blood flow, and calming chronic inflammation.

In AGA management, a realistic design is to suppress the androgen axis with finasteride or dutasteride, push the hair cycle with minoxidil, and then bring in stem cell conditioned media in the role of “restoring follicular reserve.”

Highly active alopecia areata is a different story. When immune cells are actively attacking follicles, the standard of care starts with dermatologic immune control — topical or intralesional steroids, JAK inhibitors for severe cases, and topical immunotherapy (SADBE, DPCP, and the like). Skipping this inflammation control and putting regenerative medicine in front risks patches continuing to expand one after another, and it does not stand as a monotherapy. The honest positioning is to bring in stem cell conditioned media in alopecia areata only after the dermatologic inflammation has been settled and the follicles have entered a recovery phase, as a recovery adjunct.

Cases where AGA and alopecia areata coexist (a diffuse pattern of thinning containing round patches) are not rare in clinical practice, and precisely such cases demand a careful alopecia areata vs AGA differential and a properly sequenced plan. For accumulated thinking on treatment design in the AGA field, please also see our related hair regenerative medicine column list here. For clinical guidelines covering alopecia in general, including alopecia areata, the guidelines published by the Japanese Dermatological Association serve as a reliable clinical reference axis.

What We Communicate at the First Consultation — So the Sequence Is Not Broken

At AVAN TOKYO Ginza, if the scalp findings raise a strong suspicion of alopecia areata, we guide the patient toward dermatologic autoimmune evaluation and inflammation control first. Only when AGA is judged to be running in parallel, or the patient has entered the recovery phase after inflammation has settled, do we switch to a design that combines stem cell conditioned media scalp injection. We understand the wish to “grow hair back quickly,” but treatment that skips the alopecia areata vs AGA differential and the appropriate initial response tends to yield little in return for the time and cost spent — and, in the end, becomes the long way around.

Frequently Asked Questions

Q. Are there cases where someone was treated as AGA with conditioned media but was later found to have alopecia areata?

Yes. Especially when small bald patches are mixed within diffuse hair loss, they are easily overlooked at the beginning, and the autoimmune background may only be suspected once a sharply demarcated patch expands during treatment. Periodic dermoscopy is useful.

Q. Can stem cell conditioned media be used in alopecia areata?

We do not recommend using it alone during a highly active, progressive phase. Once dermatologic immune control with steroids or topical immunotherapy has worked and the inflammation has settled, an adjunctive role can be considered during the follicular recovery phase.

Q. Can I check for exclamation-mark hairs or perform a pull test on myself?

Self-assessment is difficult and misjudgment can cause unnecessary anxiety. When you notice sharply bordered patches or rapid progression, we recommend visiting a dermatology or hair-specialty clinic first.

Q. What tests are needed for the alopecia areata vs AGA differential?

History taking, inspection, dermoscopy, and the pull test cover most of the judgment. When appropriate, we add blood tests such as thyroid function, autoantibodies, and ferritin to check for other internal backgrounds. Imaging studies are generally not required.

Q. How long does it take to judge whether the treatment is working?

Stem cell conditioned media must be evaluated along the hair cycle; in the AGA field, we typically watch progress for at least 3 to 6 months. Spontaneous recovery and treatment response in alopecia areata are also assessed on a monthly scale, so “judging within a few weeks” is far too early a time frame in both cases.

──────────────

【Supervisor】Shin Moriwaki, MD (Supervising Physician)

Member, Japan Society of Aesthetic Surgery (JSAS) / Member, American Academy of Aesthetic Medicine

ECFMG Certificate

──────────────

📍AVAN TOKYO Ginza Hair Regenerative Medicine

AVAN TOKYO Ginza Hair Regenerative Medicine

English / 中文 / Tiếng Việt supported

Inquiries welcome via DM / LINE / Website / Phone.